MarketPeel
Insider Trading Intelligence
Pricing
…
VL

Versant Ventures Vi Gp-gp, Llc

LENZ
10% OWNER · LENZ THERAPEUTICS, INC. · CIK 0001777652
FILING MIX · LIFETIME37%/63%
BUYS
36
SELLS
62
TOTAL VALUE
$96.08M
COMPANIES
6
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
17,729,423
AVG SELL PX
$17.13
TRADE KIND
SHOWING 98 / 98
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
46 backtested trades · 8 horizons · 72 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Versant Ventures Vi Gp-gp, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d46+50.00%+1.20%+0.48%+0.72%+0.33%0.57
14d46+43.48%+1.32%+1.31%+0.01%+1.81%0.01
30d46+50.00%-3.29%+2.54%-5.83%-0.19%-2.44
60d46+69.57%-6.04%+3.81%-9.85%-21.18%-2.19
90d46+73.91%-20.16%+4.30%-24.46%-31.82%-4.85
180d46+91.30%-54.38%+4.19%-58.57%-71.31%-15.42
1y46(29 pending)+70.59%-37.58%+16.48%-54.05%-50.85%—
2y46(43 pending)+33.33%-78.84%+14.84%-93.69%-92.71%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LENZ · 1,133,842 shares · as of Sep 30, 2025
0491,819983,6381,475,4561,967,2752025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 36 buys / 62 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LENZ
LENZ THERAPEUTICS, INC.
SALE
123$47.01$5.8K764,127Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
57,502$46.41$2.67M764,250Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
34,405$45.35$1.56M821,752Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
83,066$46.41$3.85M1,050,776Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
177$47.01$8.3K1,050,599Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
49,701$45.35$2.25M1,133,842Sep 30, 2025Oct 2, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
40,907$43.00$1.76M1,183,811Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
20,148$43.00$866.4K856,289Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
132$43.30$5.7K856,157Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
24,370$41.59$1.01M876,437Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
49,479$41.59$2.06M1,224,718Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
268$43.30$11.6K1,183,543Sep 18, 2025Sep 22, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
3,465$39.50$136.9K1,274,197Aug 26, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
1,707$39.50$67.4K900,807Aug 26, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
21,661$38.97$844.2K902,514Aug 26, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
43,978$38.97$1.71M1,277,662Aug 26, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
24,760$39.53$978.7K925,233Aug 25, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
50,270$39.53$1.99M1,323,789Aug 25, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
2,149$39.92$85.8K1,321,640Aug 25, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
1,058$39.92$42.2K924,175Aug 25, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
2,809$40.59$114.0K949,993Aug 22, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
5,668$40.59$230.1K1,374,059Aug 22, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
10,076$40.03$403.3K952,802Aug 22, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
20,493$40.03$820.3K1,379,727Aug 22, 2025Aug 26, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
15,085$38.56$581.7K962,878Aug 18, 2025Aug 19, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
30,628$38.56$1.18M1,400,220Aug 18, 2025Aug 19, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
145,051$39.50$5.73M1,430,848Aug 15, 2025Aug 19, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
69,949$39.50$2.76M977,963Aug 15, 2025Aug 19, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
191,376$34.00$6.51M1,575,899Jul 10, 2025Jul 14, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
200,000$30.47$6.09M1,767,275Jun 27, 2025Jul 1, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
133,924$30.25$4.05M1,967,275Jun 20, 2025Jun 20, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
100,877$30.35$3.06M1,047,912Jun 20, 2025Jun 20, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
100,000$29.95$3.00M1,148,789Jun 18, 2025Jun 20, 2025 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
SALE
350,000$29.00$10.15M1,248,789Jun 10, 2025Jun 12, 2025 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
15,600$9.41$146.8K1,573,453Oct 29, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
52,305$9.08$475.0K1,589,053Oct 29, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
5,454——0Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
89,990$9.66$869.2K2,007,948Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
366,590——1,641,358Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
20,397——0Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
17,595——0Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
5,499——0Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
5,499——5,499Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
17,595——17,595Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
20,397——20,397Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
5,454——5,454Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
1,019,867——4,079,469Oct 28, 2024Oct 30, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
1,132,566$6.53$7.40M5,099,336Sep 20, 2024Sep 24, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
9,269$6.16$57.1K6,231,902Sep 13, 2024Sep 13, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
16,047$6.00$96.3K6,241,171Sep 12, 2024Sep 13, 2024 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
541,897$6.00$3.25M6,257,218Sep 11, 2024Sep 13, 2024 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
SALE
387,999$1.10$427.0K209,941Aug 12, 2024Aug 12, 2024 ↗View →
TPST
TEMPEST THERAPEUTICS, INC.
SALE
400,000$1.35$540.0K597,940Aug 8, 2024Aug 12, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
70,498——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
148,312——148,312Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
57,565——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
275,769——710,494Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
689——12,123Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
298,975——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
317,988——1,741,107Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
434,725——434,725Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
2,182——11,434Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
22,312——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
145——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
9,252——9,252Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,931——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,476,446——1,476,446Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
348,143——1,824,589Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
455——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
110,187——1,934,776Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
391,785——391,785Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,423,119——1,423,119Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
90,747——0Apr 9, 2024Apr 11, 2024 ↗View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
2,531——2,531Apr 9, 2024Apr 11, 2024 ↗View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASE
598,203——842,162Mar 21, 2024Mar 25, 2024 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
364,800——11,452,014Aug 9, 2022Aug 11, 2022 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
550,000$13.03$7.17M11,816,814Aug 9, 2022Aug 11, 2022 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
178,996——12,366,814Jan 31, 2022Feb 2, 2022 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
371,004——12,545,810Dec 23, 2021Dec 28, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
3,000,000——0Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
20,004,280——0Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
2,699,328——0Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
6,515,869——6,799,115Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
157,895$19.00$3.00M2,097,938Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASE
1,940,043——1,940,043Jun 28, 2021Jun 30, 2021 ↗View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
4,150,000——0Jun 28, 2021Jun 30, 2021 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
25,000,000——0Jun 22, 2021Jun 23, 2021 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
PURCHASE
100,000$20.00$2.00M714,095Jun 22, 2021Jun 23, 2021 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
SALE
1,545,125——0Jun 22, 2021Jun 23, 2021 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
PURCHASE
9,936,011——12,916,814Jun 22, 2021Jun 23, 2021 ↗View →
IPSC
CENTURY THERAPEUTICS, INC.
PURCHASE
614,095——614,095Jun 22, 2021Jun 23, 2021 ↗View →
PASG
PASSAGE BIO, INC.
SALE
2,977,242——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
SALE
708,352——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
1,049,175——4,026,417Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
708,352——708,352Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
SALE
1,049,175——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
225,000$18.00$4.05M933,352Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
2,977,242——2,977,242Mar 3, 2020Mar 3, 2020 ↗View →
Other insiders · LENZ
Loading peer insiders…
About this filer
CIK 0001777652
ROLE
10% Owner
PRIMARY
LENZ
COMPANIES
6
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001777652DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback